Full Text
The Full Text of this article is available as a PDF (28.5 KB).
References
- 1. Palta S, Pai AM, Gill KS, Pai RG: New insights into the progression of aortic stenosis. Circulation 2000; 101(21): 2497 [DOI] [PubMed] [Google Scholar]
- 2. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD: Characterization of the early lesion of “degenerative” valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90(2): 844–853 [DOI] [PubMed] [Google Scholar]
- 3. Deutscher S, Rockette HE, Krishnaswami V: Diabetes and hyper‐cholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984; 37(5): 407–415 [DOI] [PubMed] [Google Scholar]
- 4. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H, Hosoe M, Itoh Y, Kawai T, Igarashi M, Shimada K: Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study.) Am J Cardiol 1995; 76(12): 928–932 [DOI] [PubMed] [Google Scholar]
- 5. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29(3): 630–634 [DOI] [PubMed] [Google Scholar]
- 6. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR: A case‐control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. Heart 1997; 78(5): 475–479 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP: Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104:2205–2209 [DOI] [PubMed] [Google Scholar]